1-3 of 3
Rosana Kapeller
Close
Sort by
Journal Articles

Anti-Leukemic Activity of the TYK2 Selective Inhibitor Ndi-031301 in T-Cell Acute Lymphoblastic Leukemia

Koshi Akahane, MD PhD, Zhaodong Li, PhD, Julia Etchin, PhD, Alla Berezovskaya, Evisa Gjini, PhD, Craig E Masse, PhD, Wenyan Miao, PhD, Jennifer Rocnik, PhD, Rosana Kapeller, MD PhD, Jeremy R Greenwood, PhD, Hong Tiv, Takaomi Sanda, MD PhD, David M Weinstock, MD, A. Thomas Look, MD
Journal: Blood
Blood (2016) 128 (22): 1596.
https://doi.org/10.1182/blood.V128.22.1596.1596
Published: 2016
Journal Articles

Synergistic Blockade Of Activated B Cell-Like DLBCL Proliferation With a Selective Inhibitor Of IRAK4 In Combination With Inhibition Of The B-Cell Receptor Signaling Network

Divya Chaudhary, Nancy Wood, Donna L. Romero, Shaughnessy D. Robinson, Jeremy R Greenwood, Mee Shelley, Michael Morin, Rosana Kapeller, William F Westlin
Journal: Blood
Blood (2013) 122 (21): 3833.
https://doi.org/10.1182/blood.V122.21.3833.3833
Published: 2013
Journal Articles

Stapled Peptides: Leveraging the BH3 α-Helix to Create a New Class of Drugs to Treat Hematological Malignancies

Rosana Kapeller, Jiawen Han, Kaiming Sun, Pranoti Gangurde, Nori Kawahata, Matt Iadanza, Vincent Guerlevais, Jim Horstick, Justin Noehre, Allen Annis, Larry Licklider, Huw M. Nash, Andrew Kung, Tomi K. Sawyer
Journal: Blood
Blood (2008) 112 (11): 2929.
https://doi.org/10.1182/blood.V112.11.2929.2929
Published: 2008